市場調查報告書

全球qPCR試劑市場:成長,趨勢,及預測

qPCR Reagents Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 922068
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
全球qPCR試劑市場:成長,趨勢,及預測 qPCR Reagents Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 111 Pages
簡介

本報告提供全球qPCR試劑市場的相關調查,市場機會和趨勢,成長及阻礙因素,各檢測方法、墊片類型、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 感染疾病及遺傳性疾病的發生率上升
    • 老年人口的增加
    • 人類基因圖譜計劃的開始、完成
  • 市場阻礙因素
    • 與PCR比較的設備的成本高
    • 為了操縱qPCR設備的技術性專門知識的缺乏
  • 波特的五力分析

第5章 市場區隔

  • 各檢測方法
    • 色素為基礎
    • 探針、底層塗料為基礎
  • 各墊片類型
    • qPCR核心套件
    • qPCR用主人混合
  • 各終端用戶
    • 醫院、診斷中心
    • 研究所、學術機構
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffman-La Roche Ltd.
    • Promega Corporation
    • Qiagen NV
    • Quanta Biosciences, Inc.
    • Sigma-Aldrich Corporation (Merck KGaA)
    • TaKaRa BIO株式會社
    • Thermo Fisher Scientific

第7章 市場機會及今後趨勢

目錄
Product Code: 67598

A real-time polymerase chain reaction (real-time PCR) or quantitative polymerase chain reaction (qPCR), is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR). It monitors the amplification of a targeted DNA molecule during the PCR.

Rising incidence of infectious diseases and genetic diseases have increased the demand for diagnostic tests that may help people take precautionary measures. Growing geriatric population has also increased the demand for fpr genetic tests. Many genome projects have been initiated in the past decade. This has allowed researchers to understand the human genome more. These projects require gene sequencing and genetic tests to understand the human gene sequence. These demand s have helped the growth of qPCR equipment, which has in turn boosted the growth of qPCR equipment market.

However, the high cost of qPCR equipment and lack of high technical expertise to operate qPCR equipment have been restraining the market growth.

Key Market Trends

Dye-Based qPCR Reagents are Expected to Dominate the Market

The use of fluorescent DNA-binding dyes is one of the most straightforward and common qPCR approaches used by scientists. A dye is added to the reaction, and fluorescence is measured at each PCR cycle. Because fluorescence of these dyes increases dramatically in the presence of double-stranded DNA, DNA synthesis can be monitored as an increase in fluorescent signal.

Dye-based diagnostic qualitative PCR is applied to rapidly detect nucleic acids that are diagnostic of, for example, infectious diseases, cancer and genetic abnormalities. Moreover, Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 2018 (17 million).

North America is Expected to Dominate the Market

Prevalence of cancer in United States is one of the highest in North American countries. According to a 2018 report by the National Cancer Institute, the incidence of cancer in the US is 439.2 per 100,000 men and women per year. Prevalence of infectious disease is also high in United States and Mexico. This has created high demand for qPCR diagnostic tests, which is increasing the demand for qPCR reagents as well.

However, the United States has a developed and well-structured health care system. The system also encourages research and development. These policies encourage global players to enter the US, and eventually the North American market. As a result, this region enjoys the presence of many global market players. As high demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

Majority of the qPCR reagents are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Infectious Diseases and Genetic Disorders
    • 4.2.2 Growing Geriatric Population
    • 4.2.3 Initiation and Completion of the Human Genome Projects
  • 4.3 Market Restraints
    • 4.3.1 Cost of the Instrument as Compared to PCR
    • 4.3.2 Lack of Technical Expertise to Operate the qPCR instrument
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Detection Method
    • 5.1.1 Dye-Based qPCR Reagents
    • 5.1.2 Probes and Primer-Based qPCR Reagents
  • 5.2 By Packaging Type
    • 5.2.1 qPCR Core Kits
    • 5.2.2 qPCR Mastermixes
  • 5.3 By End-User
    • 5.3.1 Hospitals & Diagnostic Centers
    • 5.3.2 Research Laboratories & Academic Institutes
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Affymetrix, Inc.
    • 6.1.2 Agilent Technologies, Inc.
    • 6.1.3 Bio-Rad Laboratories, Inc.
    • 6.1.4 F. Hoffman-La Roche Ltd.
    • 6.1.5 Promega Corporation
    • 6.1.6 Quanta Biosciences, Inc.
    • 6.1.7 Sigma-Aldrich Corporation (Merck KGaA)
    • 6.1.8 Takara Bio Inc.
    • 6.1.9 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS